Sachem Capital Corp. 6.00% Note
Sachem Capital Corp. 6.00% Note (SCCE) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Sachem Capital Corp. 6.00% Note (SCCE), covering cash flow, earnings, and balance sheets.
Sachem Capital Corp. 6.00% Note (SCCE) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Sachem Capital Corp. 6.00% Note SCCE financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $11.44M | $25.84M | $14.79M | -$330000.00 |
| Cost of Revenue | $0.00 | $15.18M | $290000.00 | -$15.48M |
| Gross Profit | $11.44M | $10.67M | $14.49M | $15.15M |
| Gross Profit Ratio | $1.00 | $0.41 | $0.98 | -$45.90 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.35M | $678426.00 | $2.30M | $2.62M |
| Operating Expenses | $10.41M | $678426.00 | $19.32M | $2.62M |
| Total Costs & Expenses | $10.41M | $15.85M | $19.61M | $2.62M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $1.17M | $0.00 | -$1.17M |
| EBITDA | $1.03M | $4.28M | -$4.82M | -$7.08M |
| EBITDA Ratio | $0.09 | $0.17 | -$0.33 | $21.45 |
| Operating Income | $1.03M | $3.10M | -$4.82M | -$2.95M |
| Operating Income Ratio | $0.09 | $0.12 | -$0.33 | $8.95 |
| Other Income/Expenses (Net) | -$1.24M | -$41.43M | -$1.32M | -$103000.00 |
| Income Before Tax | -$213000.00 | -$38.32M | -$6.15M | -$3.06M |
| Income Before Tax Ratio | -$0.02 | -$1.48 | -$0.42 | $9.26 |
| Income Tax Expense | $0.00 | -$42.85M | $0.00 | $0.00 |
| Net Income | -$213000.00 | -$38.32M | -$6.15M | -$3.06M |
| Net Income Ratio | -$0.02 | -$1.48 | -$0.42 | $9.26 |
| EPS | -$0.005 | $0.11 | -$0.10 | -$0.09 |
| Diluted EPS | -$0.005 | $0.15 | -$0.14 | -$0.09 |
| Weighted Avg Shares Outstanding | $46.78M | $58.89M | $58.89M | $47.50M |
| Weighted Avg Shares Outstanding (Diluted) | $44.24M | $44.24M | $44.24M | $47.50M |
Financial performance has remained strong, with revenue growing from -$330000.00 in Q2 2024 to $11.44M in Q1 2025. Gross profit continued to perform well, with margins at 100% in the latest quarter. Operating income reached $1.03M in Q1 2025, holding a steady 9% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.03M. Net income rose to -$213000.00, keeping EPS at -$0.005. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan